Skip to main content
Figure 1 | Arthritis Research & Therapy

Figure 1

From: The potential of human regulatory T cells generated ex vivo as a treatment for lupus and other chronic inflammatory diseases

Figure 1

The role of transforming growth factor-β (TGF-β) in the differentiation pathway of CD8+ regulatory T cells. In response to antigen stimulation, the combination of IL-2 produced by CD4+ cells and the active form of TGF-β produced by natural killer (NK) cells or macrophages (not shown) induce CD8+ cells to lose their cytotoxic potential and become regulatory, TGF-β-producing, Th3-like cells. IL-2 also enhances the extracellular conversion of TGF-β from the latent to the biologically active form.

Back to article page